Key result
Yeast-encoded macrocyclic peptides potently inhibit hACE2 with Ki values as low as ~1.5 nM.
Why the study?
Macrocyclic peptides are valuable drug development formats bridging small molecules and biologics, but rapid discovery methods like yeast display technology needed evaluation for identifying human angiotensin-converting enzyme 2 inhibitors.
Yeast display technology can rapidly identify macrocyclic peptides with low-nanomolar inhibitory potency against hACE2, offering a valid approach for early-stage therapeutic development.
Should not yet change clinical practice; extends yeast display as platform for macrocyclic ACE2 inhibitor development.
Macrocyclic peptides (MPs) are valuable molecular formats for drug development, bridging small molecules and larger biologics due to their favorable pharmacological properties. Here, we describe the discovery of low-nanomolar inhibitors of human angiotensin-converting enzyme 2 (hACE2) by quantitatively screening millions of structurally diverse disulfide-cyclized peptide ligands using yeast display technology. The most potent yeast-encoded “one-ring” and “two-ring” MP inhibit hACE2 with Ki values of 1.9 and 1.5 nM, respectively. These inhibitory potencies are comparable to those of other cyclic peptides discovered using well-established in vitro display technologies. Crystal structures of the two MPs in complex with hACE2 reveal the adoption of either a rigid β-hairpin or a cysteine-stabilized α-helix/α-helix motif. Both MPs exhibit binding modes distinct from those of previously reported inhibitors. Thus, yeast display is a valid technology to rapidly generate MPs with desired binding properties for the development of potential therapeutics.
No takes yet. Share an insight, caveat, or question.
Romanyuk et al. (2026) studied this question. Yeast-encoded one-ring and two-ring macrocyclic peptides potently inhibited human angiotensin-converting enzyme 2 with Ki values of 1.9 and 1.5 nM, respectively.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: